simendan has been researched along with lactic acid in 18 studies
*Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed) [MeSH]
*Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 10 (55.56) | 29.6817 |
| 2010's | 6 (33.33) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Du Toit, EF; McCarthy, J; Muller, CA; Opie, LH | 1 |
| Barán, M; Canales, HS; Dubin, A; Edul, VS; Estenssoro, E; Maskin, B; Murias, G; Pozo, MO; Sottile, JP | 1 |
| Algotsson, L; Liao, Q; Metzsch, C; Steen, S | 1 |
| Barán, M; Canales, HS; Dubin, A; Edul, VS; Estenssoro, E; Etcheverry, G; Maskin, B; Murias, G; Pozo, MO; Sottile, JP | 1 |
| Bickenbach, J; Bleilevens, C; Fries, M; Ince, C; Mik, EG; Rex, S; Rossaint, R | 1 |
| Boethig, D; Goerler, H; Huber, D; Osthaus, WA; Sasse, M; Sümpelmann, R; Winterhalter, M | 1 |
| Abdullah, GM; Alhashemi, JA; Alotaibi, QA; Shalabi, SA | 1 |
| Algotsson, L; Liao, Q; Linnér, R; Metzsch, C; Steen, S | 1 |
| Blomquist, S; Cunha-Goncalves, D; Dahm, PL; Grins, E; Perez-de-Sa, V; Thörne, J | 1 |
| Blomquist, S; Cunha-Goncalves, D; Larsson, A; Perez-de-Sa, V; Thörne, J | 1 |
| Bassiakou, E; Dontas, I; Goulas, S; Koudouna, E; Kouskouni, E; Papadimitriou, L; Perrea, D; Rokas, G; Xanthos, T | 1 |
| Bracht, H; De Backer, D | 1 |
| Bravo, MC; Bravo, Mdel C; Cabañas, F; López, P; Pellicer, A; Pérez-Fernández, E; Pérez-Rodríguez, J; Quero, J | 1 |
| Bendall, J; Chew, MS; Hawthorne, WJ; Huang, S; McLean, A; Simond, D; Ting, I; Whereat, S | 1 |
| Dong, L; Fan, Y; Ji, M; Li, GM; Li, R; Peng, YG; Wu, J; Yang, J | 1 |
| Hu, MH; Ji, CL; Lai, ZZ; Meng, JB; Tian, S; Xu, XJ; Zhang, G | 1 |
| Bergounioux, J; Essid, A; Haegy, I; Josseran, L; Mbieleu, B; Sumanaru, D | 1 |
| Chen, J; Chen, WT; Lei, YY; Lin, XF; Liu, DH; Liu, YY; Ning, YL; Xian, SX; Yang, ZQ | 1 |
1 review(s) available for simendan and lactic acid
| Article | Year |
|---|---|
Levosimendan versus dobutamine for sepsis-induced cardiac dysfunction: a systematic review and meta-analysis.
Topics: Disease-Free Survival; Dobutamine; Heart Diseases; Lactic Acid; Sepsis; Simendan; Stroke Volume; Survival Rate | 2021 |
1 trial(s) available for simendan and lactic acid
| Article | Year |
|---|---|
Levosimendan Versus Dobutamine in Myocardial Injury Patients with Septic Shock: A Randomized Controlled Trial.
Topics: Biomarkers; Demography; Dobutamine; Fatty Acid-Binding Proteins; Female; Hemodynamics; Humans; Hydrazones; Lactic Acid; Male; Middle Aged; Multivariate Analysis; Myocardium; Natriuretic Peptide, Brain; Pyridazines; Regression Analysis; Shock, Septic; Simendan; Troponin I; Ventricular Function, Left | 2016 |
16 other study(ies) available for simendan and lactic acid
| Article | Year |
|---|---|
Levosimendan: effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart.
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Agonists; Calcium Channel Blockers; Cyclic AMP; Cyclic GMP; Dobutamine; Glyburide; Guinea Pigs; Heart; Hydrazones; In Vitro Techniques; L-Lactate Dehydrogenase; Lactic Acid; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nucleotides, Cyclic; Phosphocreatine; Pyridazines; Simendan; Stereoisomerism | 1999 |
Effects of levosimendan in normodynamic endotoxaemia: a controlled experimental study.
Topics: Acidosis; Animals; Disease Models, Animal; Endotoxemia; Escherichia coli Infections; Hemodynamics; Hydrazones; Intestinal Mucosa; Lactic Acid; Oxygen; Pyridazines; Sheep; Simendan; Vasodilator Agents | 2006 |
Levosimendan cardioprotection reduces the metabolic response during temporary regional coronary occlusion in an open chest pig model.
Topics: Animals; Cardiac Output; Cardiotonic Agents; Coronary Circulation; Glucose; Hydrazones; Infusions, Intravenous; Lactic Acid; Microdialysis; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Myocardium; Pyridazines; Pyruvic Acid; Simendan; Sus scrofa | 2007 |
Effects of levosimendan and dobutamine in experimental acute endotoxemia: a preliminary controlled study.
Topics: Acidosis; Analysis of Variance; Animals; Cardiotonic Agents; Dobutamine; Endotoxemia; Hydrazones; Lactic Acid; Oxygen; Prospective Studies; Pyridazines; Random Allocation; Sheep; Shock, Septic; Simendan; Splanchnic Circulation | 2007 |
Levosimendan but not norepinephrine improves microvascular oxygenation during experimental septic shock.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Fluid Therapy; Hemodynamics; Hydrazones; Lactic Acid; Male; Microcirculation; Mouth Mucosa; Norepinephrine; Oxygen; Pyridazines; Rats; Rats, Sprague-Dawley; Shock, Septic; Simendan; Vasodilator Agents | 2008 |
First experiences with intraoperative Levosimendan in pediatric cardiac surgery.
Topics: Cardiac Output; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Heart; Heart Defects, Congenital; Hemodynamics; Humans; Hydrazones; Infant; Infant, Newborn; Infusions, Intravenous; Intraoperative Period; Lactic Acid; Length of Stay; Oxygen; Postoperative Complications; Pyridazines; Respiration, Artificial; Retrospective Studies; Simendan; Transposition of Great Vessels | 2009 |
Levosimendan vs dobutamine in septic shock.
Topics: APACHE; Cardiotonic Agents; Dobutamine; Humans; Hydrazones; Lactic Acid; Pyridazines; Randomized Controlled Trials as Topic; Shock, Septic; Simendan | 2009 |
Levosimendan cardioprotection in acutely beta-1 adrenergic receptor blocked open chest pigs.
Topics: Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Clinical Protocols; Female; Glucose; Glycerol; Hemodynamics; Hydrazones; Lactic Acid; Male; Metoprolol; Microdialysis; Myocardial Ischemia; Myocardial Reperfusion Injury; Pyridazines; Pyruvic Acid; Simendan; Swine; Thoracic Surgical Procedures; Treatment Outcome | 2010 |
Inotropic support during experimental endotoxemic shock: part I. The effects of levosimendan on splanchnic perfusion.
Topics: Animals; Blood Pressure; Blood Volume; Cardiac Output; Cardiotonic Agents; Combined Modality Therapy; Disease Models, Animal; Fluid Therapy; Heart Rate; Hemodynamics; Hydrazones; Hypotension; Lactic Acid; Lipopolysaccharides; Liver Circulation; Oxygen; Pyridazines; Regional Blood Flow; Shock, Septic; Simendan; Splanchnic Circulation; Swine; Time Factors; Vascular Resistance | 2009 |
Inotropic support during experimental endotoxemic shock: part II. A comparison of levosimendan with dobutamine.
Topics: Animals; Blood Pressure; Blood Volume; Cardiac Output; Cardiotonic Agents; Combined Modality Therapy; Disease Models, Animal; Dobutamine; Drug Therapy, Combination; Fluid Therapy; Heart Rate; Hemodynamics; Hydrazones; Hypotension; Lactic Acid; Lipopolysaccharides; Liver Circulation; Norepinephrine; Oxygen; Pyridazines; Regional Blood Flow; Shock, Septic; Simendan; Splanchnic Circulation; Swine; Time Factors; Vascular Resistance | 2009 |
Combination pharmacotherapy in the treatment of experimental cardiac arrest.
Topics: Adrenergic beta-Agonists; Animals; Atenolol; Cardiotonic Agents; Disease Models, Animal; Drug Therapy, Combination; Epinephrine; Heart Arrest; Hydrazones; Lactic Acid; Phosphopyruvate Hydratase; Pyridazines; S100 Proteins; Simendan; Swine; Troponin I | 2009 |
Levosimendan in early sepsis: when good ideas give poor results.
Topics: Animals; Blood Pressure; Blood Volume; Cardiac Output; Cardiotonic Agents; Combined Modality Therapy; Fluid Therapy; Heart Rate; Hemodynamics; Humans; Hydrazones; Lactic Acid; Liver Circulation; Oxygen; Pyridazines; Regional Blood Flow; Shock, Septic; Simendan; Splanchnic Circulation; Time Factors; Vascular Resistance | 2009 |
Acute effects of levosimendan on cerebral and systemic perfusion and oxygenation in newborns: an observational study.
Topics: Blood Pressure; Cardiac Output, Low; Cardiotonic Agents; Cerebrovascular Circulation; Heart Defects, Congenital; Heart Rate; Hemoglobins; Humans; Hydrazones; Infant, Newborn; Lactic Acid; Prospective Studies; Pyridazines; Respiration; Simendan; Statistics, Nonparametric | 2011 |
No beneficial effects of levosimendan in acute porcine endotoxaemia.
Topics: Animals; Blood Pressure; Cardiotonic Agents; Cytokines; Echocardiography; Endotoxemia; Heart Function Tests; Hemodynamics; Hydrazones; Hypertension, Pulmonary; Kidney Function Tests; Lactic Acid; Lipopolysaccharides; Liver Function Tests; Pulmonary Circulation; Pyridazines; Regional Blood Flow; Sample Size; Simendan; Swine; Water-Electrolyte Balance | 2011 |
Effects of combined levosimendan and vasopressin on pulmonary function in porcine septic shock.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Drug Therapy, Combination; Female; Hemodynamics; HMG-Box Domains; Hydrazones; Inflammation; Interleukin-6; Lactic Acid; Lung; Nitrates; Nitrites; Norepinephrine; Peritonitis; Pulmonary Artery; Pulmonary Gas Exchange; Pyridazines; Random Allocation; Respiratory Physiological Phenomena; Shock, Septic; Simendan; Swine | 2012 |
Levosimendan as Rescue Therapy for Acute Heart Failure in a Patient with Duchenne Muscular Dystrophy.
Topics: Acute Disease; Adult; Cardiomyopathies; Cardiotonic Agents; Heart Failure; Humans; Lactic Acid; Male; Muscular Dystrophy, Duchenne; Natriuretic Peptide, Brain; Pneumonia; Simendan | 2019 |